PPT-Javelin
A Phase III openlabel multicenter trial of avelumab MSB0010718C versus platinumbased doublet as a firstline treatment of recurrent or Stage IV PDL1 nonsmall cell
Download Presentation
"Javelin" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.